Ocugen ($OCGN) Insider Trading & Smart Money Activity

Ocugen, Inc. · Biotechnology · Latest filing Oct 9, 2026

Ocugen, Inc. ($OCGN) has 3 insider trades and 2 13F position changes on file. In the last 12 months on the open market, 1 insider bought ($25.83K) and 1 insider sold ($499.69K), net -$473.86K.

Insider buyers (12 mo): 1
Insider sellers (12 mo): 1
Net insider $ (12 mo): -$473.86K
Congress trades (12 mo): 0
13F moves on file: 2
Analyst ratings on file: 0

OCGN insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	1 · $25.83K	0	0 / 0	2 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	1 · $499.69K	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All OCGN insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
Oct 9, 2026	Insider	Musunuri ShankarChief Executive Officer	Sell (Open-market sale) 10b5-1	525.99K sh	$499.69K	-18.7%		Read
Jun 15, 2026	Insider	Johnson-Greene Treerita EssalimaChief Financial Officer	Buy (Open-market buy)	21K sh	$25.83K	+5.7%	+17.2%	—
Jun 11, 2026	Insider	Satishchandran Chandrasekhar	Buy (Grant or award)	170.10K sh		+1.6%	+15.6%	—
May 15, 2026	13F	Rtw Investments	New	+6.67M sh	$10.20M	-3.6%	-12.2%	Read
May 15, 2026	13F	Rtw Investments	New	+6.67M sh	$8.07M	-3.6%	-12.2%	Read

1W / 1M / 6M = how OCGN moved from the trade or filing date.

Insider trading in OCGN: who is buying and selling

Insider	Role	Trades	Open-market net	Last trade
Musunuri Shankar	Chief Executive Officer	1	-$499.69K	Oct 9, 2026
Johnson-Greene Treerita Essalima	Chief Financial Officer	1	+$25.83K	Jun 15, 2026
Satishchandran Chandrasekhar		1	—	Jun 11, 2026

Institutions moving OCGN (13F)

Rtw Investments2

Frequently asked questions

Are OCGN insiders buying or selling?

Over the last 12 months 1 insider made 1 open-market purchase worth $25.83K and 1 insider made 1 open-market sale worth $499.69K, a net -$473.86K.

What is the latest insider trade in OCGN?

Musunuri Shankar, Chief Executive Officer filed a sell (open-market sale) of 525.99K sh worth $499.69K on Oct 9, 2026.

Which institutions changed their OCGN positions?

Recent 13F filers moving the stock include Rtw Investments.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text